~~<i id='D9EE5E5159'><strike id='D9EE5E5159'><tt id='D9EE5E5159'><pre id='D9EE5E5159'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：leisure time 2025-09-29 00:27:16 - browse：493

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Hospital price transparency does save money, advocate argues

hotspot

Wikipedia

explore

Wikipedia

Photoillustration:CaseySheneryforSTATHowoldisClaireSnyman?“Iamnow…”shesayswithpause.“Ialwayshavetoth

WSS

The explosion of genetic testing requires a new approach

Life sciences investors close nearly $6 billion in new funds

All of Us, NIH's precision medicine initiative, gets a big boost

How to convince healthy people to buy insurance

Inari Medical to buy amputation prevention company LimFlow

Key Senate panel to consider PBM, drug pricing reform package

hotspot

entertainment

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

All of Us, NIH's precision medicine initiative, gets a big boost

DIEP, the 'gold standard' of breast reconstruction, is under threat

Researchers explore possible ties between long Covid, menopause

Psychedelics group wrestles with new pharma identity

UnitedHealth’s board chair also owns a personal investment firm

Apple is now the first public company to be valued at $3 trillion

HHS leader on health, climate change and biopharma emissions

Trump demands the U.S. pay no more for drugs than other countries … again

Lung cancer screening guidelines updated for cigarette smokers

hotspot

Live blog: Hearing on CRISPR

Lung cancer screening guidelines updated for cigarette smokers

Studies point to risks of excluding people with obesity from drug trials

The health care issue Democrats can’t solve: hospital reform

Bill would allow buprenorphine prescription for addiction via telehealth

STAT Summit: Michael J. Fox on progress in Parkinson's research

Wikipedia

explore

explore

Wikipedia